Cross-cultural Adaptation and Validation of the Arabic Neuro QOL Questionnaire for Quality of Life in Adults with Diabetic Neuropathy

What this Trial Is About

Researchers are conducting a study to translate, culturally adapt, validate, and test the reliability of the Neuro Qol questionnaire in Arabic for diabetic patients with peripheral neuropathy and diabetic foot ulcers. This cross-cultural validation aims to produce a version suitable for use in Arabic-speaking countries, as no Arabic version currently exists. The study focuses on assessing quality of life related to neuropathy and foot ulcers among Arabic-speaking diabetic patients. The study involves translating the Neuro Qol questionnaire through a careful process including forward and backward translation, expert panel review, and harmonization. Participants include 290 diabetic patients aged 18 to 70 years who can read and write Arabic. They will complete the Arabic Neuro Qol as well as the Michigan Diabetic Neuropathy Scale MDNS in Arabic. The study includes two clinic visits spaced 7 to 14 days apart, with clinical examinations and data collection performed by trained staff. Participants will be initially screened and consented during the first visit, where demographic and clinical data will be collected. At the second visit, patients will complete additional questionnaires and report symptoms. Researchers will measure the cross-cultural validity, reliability, and adaptation of the Arabic Neuro Qol over an average of six months. The study will also monitor for diabetic neuropathy symptoms and related complications to ensure comprehensive assessment.

Cross-cultural Adaptation and Validity of the Arabic-translated NEUROPATHY-SPECIFIC QUALITY OF LIFE Questionnaire